万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.jcytol.org/
3、投稿网址：https://review.jow.medknow.com/joc
4、官网邮箱：editor@jcytol.org
5、官网电话：09868169645
6、期刊刊期：季刊，一年出版4期。
2021年10月20日星期三
投稿须知【官网信息】
Instructions to Authors
Journal of Cytology (JOC) a peer-reviewed international journal is being published under the auspices of the Indian Academy of Cytologists.
The journal’s full text is online at www.jcytol.org . With the aim of faster and better dissemination of knowledge, we will be publishing articles ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in JOC.
Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (October 2006). The uniform requirements and specific requirement of JOC are summarized below. Before sending a manuscript contributors are requested to check for the latest instructions available. Instructions are also available from the website of the journal ( https://www.jcytol.org ) and from the manuscript submission site ( https://review.jow.medknow.com/joc ).
Scope of the journal
The journal will cover all aspects of diagnostic cytology, including fine needle aspiration cytology, gynecological and non-gynecological cytology. Articles on ancillary techniques, like cytochemistry, immunocytochemistry, electron microscopy, molecular cytopathology, as applied to cytological material are also welcome. The journal gives preference to clinically oriented studies over experimental and animal studies. The Journal would publish peer-reviewed original research papers, case reports, systematic reviews, meta-analysis, and debates.
The Editorial Process
The manuscripts will be reviewed for possible publication with the understanding that they are being submitted to one journal at a time and have not been published, simultaneously submitted, or already accepted for publication elsewhere.
The Editors review all submitted manuscripts initially. Manuscripts with insufficient originality, serious scientific and technical flaws, or lack of a significant message are rejected. All manuscripts received are duly acknowledged. Manuscripts are sent to two or more expert reviewers without revealing the identity of the contributors to the reviewers. Each manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The contributors will be informed about the reviewers' comments and acceptance/rejection of manuscript.
Articles accepted would be copy edited for grammar, punctuation, print style, and format. Page proofs will be sent to the corresponding author, which has to be returned within three days. Correction received after that period may not be included.
Clinical trial registry
All clinical trials from India must be registered with “clinical trials registry – India” . The trials conducted outside India may be registered with any other clinical trial registry. The Indian council of medical research has recommended making it mandatory to have registration number for all clinical trials submitted for publication from January 2009.
Authorship Criteria
Authorship credit should be based only on substantial contributions
Conception and design or acquisition of data or analysis and interpretation of data;
Drafting the article or revising it critically for important intellectual content;
Final approval of the version to be published.
Conditions 1, 2, and 3 must be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.
For a study from in a single institute the number of contributors should not exceed six. For a case-report, images, letter to the editor and review article the number of contributors should not exceed four. A justification should be included, if the number of contributors exceeds these limits.
Only those who have done substantial work in a particular field can write a review article. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript. The journal expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of article and should be sent as a letter to editor, as and when major development occurs in the field.
Contribution Details
Contributors should provide a description of what each of them contributed towards the manuscript. Description should be divided in following categories, as applicable:
concepts, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript
preparation, manuscript editing and manuscript review. Authors' contributions will be printed on the first page of the article. One or more author should take responsibility of
the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.
Conflicts of Interest
All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or is
important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The
Editor will discuss with the authors on an individual basis the method by which any conflicts of interest will be communicated to the readers.
Copies of any permission(s)
To reproduce published material, and to use illustrations or report information about identifiable people a copy of the permission obtained must accompany the manuscript.
Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.
The manuscript should be sent
Journal of Cytology,
Col Prabal Deb
Department of Pathology,
Army Hospital (Research & Referral)
New Delhi - 110 010
India
Types of Manuscripts and Limits
Original Articles: Randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, cost effectiveness analyses, case-control series, and surveys with high response rate. Up to 3000 words excluding about 30 references and abstract.
Review Articles (including for Ethics forum, Education forum, E-Medicine, etc.): Systemic critical assessments of literature and data sources. Up to 4000 words excluding about 90 references and abstract. For review articles, include the method (literature search) in abstract as well as in the introduction section.
Case reports: new/interesting/very rare cases can be reported. Cases with clinical significance or implications will be given priority. However, mere reporting of a rare case may not be considered. Up to 1000 words excluding references and abstract and up to 10 references.
Images in Cytopathology: a short history, photograph, differential diagnosis, and short discussion of classic and/or rare case. Should not be more than 800 words excluding up to six references.
Spot the Diagnosis: A classical clinical, pathological or other signs can be submitted as spot the diagnosis. Up to 400 words excluding up to 4 references.
……
更多详情：
https://www.jcytol.org/contributors.asp
